<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2216-0973</journal-id>
<journal-title><![CDATA[Revista Cuidarte]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cuid]]></abbrev-journal-title>
<issn>2216-0973</issn>
<publisher>
<publisher-name><![CDATA[Programa de Enfermería, Facultad de Ciencias de la Salud, Universidad de Santander UDES]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2216-09732017000301826</article-id>
<article-id pub-id-type="doi">10.15649/cuidarte.v8i3.436</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Qualidade de vida relacionada à saúde de pacientes com câncer de próstata]]></article-title>
<article-title xml:lang="en"><![CDATA[Quality of life related to the health of patients with prostate cancer]]></article-title>
<article-title xml:lang="es"><![CDATA[Calidad de vida relacionada con la salud de los pacientes con cáncer de próstata]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quijada]]></surname>
<given-names><![CDATA[Patrícia Daniela dos Santos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[Paolla Algarte]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[Salvador Boccaletti]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[Branca Maria de Oliveira]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidade de Franca  ]]></institution>
<addr-line><![CDATA[Franca São Paulo]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade de Franca  ]]></institution>
<addr-line><![CDATA[Franca São Paulo]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidade de Franca  ]]></institution>
<addr-line><![CDATA[Franca São Paulo]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidade de Franca  ]]></institution>
<addr-line><![CDATA[Franca São Paulo]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<numero>3</numero>
<fpage>1826</fpage>
<lpage>1838</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S2216-09732017000301826&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S2216-09732017000301826&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S2216-09732017000301826&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução: O diagnóstico e o tratamento do câncer de próstata podem provocar modificações significativas na vida dos homens, alterando a sua qualidade de vida. O objetivo deste estudo foi avaliar a qualidade de vida relacionada à saúde de pacientes com câncer de próstata em tratamento de hormonioterapia e radioterapia.  Materiais e Métodos: Estudo descritivo, transversal, com dados sociodemográficos, clínicos e de avaliação da qualidade de vida de 213 pacientes, obtidos por roteiro de entrevista e pelo questionário Expanded Prostate Cancer Index Composite. Utilizou-se estatística descritiva.  Resultados: Houve predominância de homens acima de 50 anos, brancos, casados, com baixa escolaridade e aposentados, com diagnóstico inicial obtido pelas alterações no exame de Antígeno Prostático Específico e estadiamento II. As médias dos escores obtidos no domínio da função sexual indicaram queda na qualidade de vida, para ambos os tratamentos.  Discussão: Tanto a hormonioterapia como a radioterapia podem causar algum tipo de efeito na função sexual, diretamente relacionado a um significativo impacto na qualidade de vida relacionada à saúde para muitos homens.  Conclusões: Ainda que os resultados tenham sido obtidos e analisados pela primeira vez no hospital do estudo, oferecem subsídios para o conhecimento da realidade local e corroboram com os achados de outros estudos realizados em locais e realidades diferentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: The diagnosis and treatment of prostate cancer can cause significant modifications in the lives of men, altering their quality of life. The aim of this study was to assess the health-related quality of life of patients with prostate cancer in hormone therapy and radiotherapy treatment.  Materials and Methods: Descriptive, cross-sectional study with sociodemographic, clinical data and quality of life evaluation of 213 patients, obtained from the interview script and through the questionnaire Expanded Prostate Cancer Index Composite. Descriptive statistics were used.  Results: There was a predominance of white men over 50 years of age, married, with low schooling, and retirees with initial diagnosis obtained by alterations on the specific prostatic antigen test and stage II. The mean scores obtained in the sexual function domain indicated a decrease in quality of life for both treatments.  Discussion: Hormone therapy and radiotherapy can cause some type of type of effect on the sexual function, directly related to a significant impact on the quality of life related to health for many men.  Conclusions: Although the results were obtained and analyzed for the first time in the study hospital, they offer subsidies for the knowledge of the local reality and corroborate with findings from other studies carried out in different places and realities.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: El diagnóstico y el tratamiento del cáncer de próstata pueden provocar cambios significativos en la vida de los hombres, alterando su calidad de vida. El objetivo de este estudio fue evaluar la calidad de vida relacionada con la salud de pacientes con cáncer de próstata en tratamiento de hormonioterapia y radioterapia.  Materiales y Métodos: Estudio descriptivo, transversal, con datos sociodemográficos, clínicos y de evaluación de la calidad de vida de 213 pacientes, obtenidos por un guión de entrevista y por el cuestionario Expanded Prostate Cancer Index Composite. Se utilizó estadística descriptiva.  Resultados: Hubo predominio de hombres mayores de 50 anos, blancos, casados, con baja escolaridad y jubilados, con diagnóstico inicial obtenido por las alteraciones en el examen de Antígeno Prostático Específico y estadio II. Las medias de las puntuaciones obtenidas en el dominio de la función sexual indicaron caída en la calidad de vida, para ambos tratamientos.  Discusión: Tanto la hormonioterapia como la radioterapia pueden causar algún tipo de efecto en la función sexual, directamente relacionado con un significativo impacto en la calidad de vida relacionada con la salud para muchos hombres.  Conclusiones: Aunque los resultados han sido obtenidos y analizados por primera vez en el hospital del estudio, ofrecen subsidios para el conocimiento de la realidad local y corroboran los resultados con otros estudios realizados en locales y realidades diferentes.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Neoplasias da Próstata]]></kwd>
<kwd lng="pt"><![CDATA[Qualidade de Vida]]></kwd>
<kwd lng="pt"><![CDATA[Terapêutica]]></kwd>
<kwd lng="pt"><![CDATA[Antineoplásicos Hormonais]]></kwd>
<kwd lng="pt"><![CDATA[Radioterapia]]></kwd>
<kwd lng="en"><![CDATA[Prostate Neoplasms]]></kwd>
<kwd lng="en"><![CDATA[Quality of Life]]></kwd>
<kwd lng="en"><![CDATA[Therapeutics]]></kwd>
<kwd lng="en"><![CDATA[Antineoplastic Hormonal]]></kwd>
<kwd lng="en"><![CDATA[Radiotherapy]]></kwd>
<kwd lng="es"><![CDATA[Neoplasias de la Próstata]]></kwd>
<kwd lng="es"><![CDATA[Calidad de Vida]]></kwd>
<kwd lng="es"><![CDATA[Terapêutica]]></kwd>
<kwd lng="es"><![CDATA[Antineoplásicos Hormonales]]></kwd>
<kwd lng="es"><![CDATA[Radioterapia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Dikshit]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Eser]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mathers]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rebelo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012]]></article-title>
<source><![CDATA[Int J Cancer]]></source>
<year>2015</year>
<volume>136</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>359-86</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde, Brasil. Instituto Nacional de Câncer</collab>
<source><![CDATA[Estimativa 2016: incidência de câncer no Brasil]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mottet]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Bellmunt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Briers]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bergh]]></surname>
<given-names><![CDATA[RCN]]></given-names>
</name>
<name>
<surname><![CDATA[Bolla]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Casteren]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines on prostate cancer]]></article-title>
<source><![CDATA[European Association of Urology]]></source>
<year>2015</year>
<page-range>1-137</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde, Brasil</collab>
<source><![CDATA[Diário Oficial [da] República Federativa do Brasil]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heidenreich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bastian]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bellmunt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bolla]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Joniau]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kwast]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent]]></article-title>
<source><![CDATA[Eur Urol]]></source>
<year>2013</year>
<volume>65</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>124-37</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Spratt]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Liss]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[McLaughlin]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2016</year>
<volume>17</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>198-208</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Litwin]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Sandler]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Sanda]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer]]></article-title>
<source><![CDATA[Urology]]></source>
<year>2000</year>
<volume>56</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>899-905</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puerto]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida en cuidadores familiares de personas en tratamiento contra el cáncer]]></article-title>
<source><![CDATA[Rev Cuid]]></source>
<year>2015</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1029-40</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Andreoni]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the Brazilian version of the Expanded Prostate Cancer Index Composite (EPIC) for patients submitted to radical prostatectomy]]></article-title>
<source><![CDATA[Int Braz J Urol]]></source>
<year>2013</year>
<volume>39</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>344-52</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde, Brasil. Conselho Nacional de Saúde</collab>
<source><![CDATA[Diário Oficial da União]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Brasília ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>American Joint Committee on Cancer (AJCC)</collab>
<source><![CDATA[Cancer staging manual. Prostate Cancer Staging]]></source>
<year>2011</year>
<edition>7th ed.</edition>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[ICS]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Barichello]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Distúrbios do sono em homens com câncer de próstata em hormonioterapia]]></article-title>
<source><![CDATA[Esc. Anna Nery]]></source>
<year>2014</year>
<volume>18</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>705-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kao]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
<name>
<surname><![CDATA[Ou]]></surname>
<given-names><![CDATA[FY]]></given-names>
</name>
<name>
<surname><![CDATA[Syu]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ou]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinants of quality of life in prostate cancer patients: A single institute analysis]]></article-title>
<source><![CDATA[Urological Science]]></source>
<year>2015</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>254-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>Ministério da Saúde, Brasil. Instituto Nacional de Câncer</collab>
<source><![CDATA[Rastreamento do Câncer de Próstata]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Rio de Janeiro ]]></publisher-loc>
<publisher-name><![CDATA[Ministério da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Brasil</collab>
<source><![CDATA[Diário Oficial da União]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<collab>Brasil</collab>
<source><![CDATA[Diário Oficial da União]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zacchi]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Amorim]]></surname>
<given-names><![CDATA[MHC]]></given-names>
</name>
<name>
<surname><![CDATA[Souza]]></surname>
<given-names><![CDATA[MAC]]></given-names>
</name>
<name>
<surname><![CDATA[Miotto]]></surname>
<given-names><![CDATA[MHMB]]></given-names>
</name>
<name>
<surname><![CDATA[Zandonade]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Associação de variáveis sociodemográficas e clínicas com o estadiamento inicial em homens com câncer de próstata]]></article-title>
<source><![CDATA[Cad Saúde Colet]]></source>
<year>2014</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>93-100</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[de Rooy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hoermann]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lim Joon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zajac]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Grossmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy]]></article-title>
<source><![CDATA[Clin Endocrinol (Oxf)]]></source>
<year>2016</year>
<volume>86</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>388-94</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Victorson]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
<name>
<surname><![CDATA[Schuette]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Schalet]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Kundu]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Helfand]]></surname>
<given-names><![CDATA[BT]]></given-names>
</name>
<name>
<surname><![CDATA[Novakovic]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors Affecting Quality of Life at Different Time Points Since Treatment in a Sample of Men with Localized Prostate Cancer: The Unique Influence of Treatment Decision Making Satisfaction, Personality and Sexual Functioning]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2016</year>
<volume>196</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1422-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Queenan]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Feldman-Stewart]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Brundage]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Groome]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Social support and quality of life of prostate cancer patients after radiotherapy treatment]]></article-title>
<source><![CDATA[Eur J Cancer Care]]></source>
<year>2010</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>251-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Atkinson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of erectile dysfunction in men treated with androgen deprivation therapy]]></article-title>
<source><![CDATA[Trends in Urology &amp; Men's health]]></source>
<year>2013</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>13-8</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stegall]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical management of erectile dysfunction]]></article-title>
<source><![CDATA[Int J Urol Nurs]]></source>
<year>2011</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>52-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mirza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Griebling]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Kazer]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Erectile dysfunction and urinary incontinence after prostate cancer treatment]]></article-title>
<source><![CDATA[Semin Oncol Nurs]]></source>
<year>2011</year>
<volume>27</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>278-89</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinkawa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Piroth]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Holy]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Djukic]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Klotz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Krenkel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combination of dose escalation with technological advances (intensity-modulated and image- guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer]]></article-title>
<source><![CDATA[Strahlenther Onkol]]></source>
<year>2011</year>
<volume>187</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>479-84</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Fujii]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Masuda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Urakami]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Saito]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kozuka]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer]]></article-title>
<source><![CDATA[Qual Life Res]]></source>
<year>2014</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1641-50</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoppe]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Nichols]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Henderson]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Morris]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2012</year>
<volume>118</volume>
<numero>18</numero>
<issue>18</issue>
<page-range>4619-26</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sveistrup]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mortensen]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
<name>
<surname><![CDATA[Bjørner]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Engelholm]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Munck]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective assessment of the quality of life before, during and after image guided intensity modulated radiotherapy for prostate cancer]]></article-title>
<source><![CDATA[Radiat Oncol]]></source>
<year>2016</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2-8</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schover]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexual healing in patients with prostate cancer on hormone therapy]]></article-title>
<source><![CDATA[Am Soc Clin Oncol Educ]]></source>
<year>2015</year>
<page-range>562-75</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benedict]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Traeger]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dahn]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Antoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Bustillo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy]]></article-title>
<source><![CDATA[J Sex Med]]></source>
<year>2014</year>
<volume>11</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2571-80</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Higano]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2012</year>
<volume>30</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>3720-5</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donovan]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Wassersug]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2015</year>
<volume>121</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>4286-99</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Kao]]></surname>
<given-names><![CDATA[LT]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Xirasagar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder]]></article-title>
<source><![CDATA[Plos One]]></source>
<year>2017</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castaneda]]></surname>
<given-names><![CDATA[ÁH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida y adherencia al tratamiento de personas con enfermedad crónica oncológica]]></article-title>
<source><![CDATA[Rev Cuid]]></source>
<year>2015</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>906-13</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cronbach]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coefficient alpha and the internal structure of the tests]]></article-title>
<source><![CDATA[Psychometrika]]></source>
<year>1951</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>297-334</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
